A-D

Alison Allan, PhD.

Associate Vice President (Research). Former Chair & Professor, Department of Anatomy and Cell Biology. Professor, Departments of Anatomy & Cell Biology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Distinguished Senior Scientist & Director, Breast Cancer Canada Translational Research Unit, Cancer Research Laboratory Program, London Sciences Health Research Institute.

Research Interests / Specializations: Breast and prostate cancer; Circulating tumor cells (CTCs); Cancer stem cells; Cellular and molecular mechanisms of metastasis; Animal models of metastasis; Primary breast cancer xenografting; Translational research

Andrew Arifin MD. FRCPC.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry. Oncologist, Division of Radiation Oncology, Verspeeten Family Cancer Centre, London Health Sciences Centre. Lead, Schulich Oncology Wellness & Resiliency Task Force. Member, Quality Improvement Lead - RO Residency Training Program.

Research Interests / Specializations: Disease Sites - Pediatrics, Sarcoma, Skin. Artificial Intelligence Applications in medicine, clinical and translational research.

Samuel Asfaha, MD. PhD. FRCPC.

Associate Professor, Departments of Medicine, and Oncology, and Physiology & Pharmacology, Schulich School of Medicine & Dentistry, Western University. CIHR Clinician Scientist, London Health Sciences Research Institute. Gastroenterologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Stem Cells, Inflamation, Colorectal Cancer, Inflammatory Bowel Disease. Main research focus areas are identifying the cellular original of colorectal cancer and understanding the processes regulating normal and mutated intestinal/colonic steam cells and predicting drug response.

Glenn Bauman, MD. FRCPC.

Distinguished University Professor, Departments of Oncology, Urology and Medical Biophysics, Schulich School of Medicine & Dentistry, Western University. Associate Scientist, London Health Sciences Research Institute and Lawson Research Institute at St. Joseph's Hospital. Director, Centre for Translational Cancer Research. Radiational Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. OICR Scientist.

Research Interests / Specializations: Image Guided Radiotherapy for CNS and GU cancers; Cancer Imaging; Clinical Trials.

Vasudeva (Vasu) Bhat. PhD.

Research Associate, Breast Cancer Canada Translational Research Unit, Cancer Research Laboratory Program, London Health Sciences Centre.

Research Interests / Specializations: Breast cancer, cancer stem cells, metastasis, lung microenvironment, tumor-immune microenvironment, liquid biopsy, organoid models, spatial omics.

Nathalie Bérubé, PhD.

Professor, Department of Anatomy and Cell Biology, Oncology, and Paediatrics, Schulich School of Medicine & Dentistry, Western University. Scientist, CHIR, Lawson Health Research Institute.

Research Interests / Specializations: Animal models of disease; Genetic mutations linked to brain tumors; Epigenetics

Phillip Blanchette, MD. FRCPC.

Associate Professor, Department of Oncology, Schulich School of Medicine & Medicine. Medical Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Scientist, ICES Western

Research Interests / Specializations: Clinical: breast and lung cancer. Research: health services research focusing on cancer clinical outcomes, health equity and drug safety.

Michael B. Boffa, PhD.

Associate Professor, Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University. Scientist, Robarts Research Institute.

Research Interests / Specializations: Studying structure/function relationships in TAFI, using molecular biological and protein biochemical approaches.

Muriel Brackstone, MD. MSc. PhD. FRCSC.

Professor, Departments of Surgery, and Oncology, Schulich School of Medicine & Dentistry, Western University. Associate Scientist, London Health Sciences Research Institute. General Surgeon, London Health Sciences Centre. Medical Director, London Breast Care Clinic, St. Joseph's Health Centre. Director, London Tumour Biobank. Former Chair/Chief, Division of General Surgery. Executive, National Cancer Institute of Canada, and Cancer Care Ontario.

Research Interests / Specializations: Neoadjuvant Breast Cancer Window of Opportunity Trials, Clinical Trials with Biospecimen Correlative Translational Trials, Oncoplastic Surgery Techniques, Young Women and Breast Cancer, Locally Advanced Breast Cancer, Immunotherapy in Breast Cancer, Immune Priming Neoadjuvant Radiation (SIGNAL Trial)

Daniel Breadner. MSc, MD. FRCPC.

Assistant Professor, Schulich School of Medicine and Dentistry, Western University. Canadian Cancer Trial Groups, Investigational New Drugs Executive Committee Member. Medical Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. London Regional Cancer Program Molecular Tumour Board Chair.

Research Interests / Specializations: Clinical: Thoracic and Gastrointestinal. Research: Clinical Research, Liquid Biopsies, Cancer Genomics/Targeted Therapy, Neoadjuvant and Window of Opportunity Treatment.

Jeremy Burton, BSc. MSc. PhD. dBA.

Associate Professor, Departments of Surgery, and Microbiology & Immunology, Schulich School of Medicine & Dentistry, Western University. Miriam Burnett Chair in Urological Science. Director, Canadian Centre for Human Microbiome and Probiotics. Scientist, Lawson Research Institute, St. Joseph's Hospital.

Research Interests / Specializations: The xenobiotic metabolism of prostate cancer drugs and the role of the microbiome in immune therapy.

Leandro Cardarelli Leite. MD.

Assistant Professor, Department of Medical Imaging, Schulich School of Medicine & Dentistry, Western University. Vascular Interventional Radiologist, London Health Sciences Centre.

Research Interests / Specializations: Palliative treatments for children and adults with cancer including cryoablation, cementoplasty, vertebroplasty, kyphoplasty, neurolysis and selective blocks. Selective internal radiation therapy (SIRT aka TARE aka Y90) for liver cancer. Treatment of vascular anomalies and vascular tumors in children and adults. Prostatic artery embolization. Complex endovascular treatments for limb salvage. Research interests include developing augmented reality solutions to decrease radiation exposure to the operator.

Jeffrey Carson, PhD.

Associate Professor, Departments of Medical Biophysics, Physics & Astronomy, and Surgery, Schulich School of Medicine & Dentistry, Western University. Imaging Scientist, Imaging Program, Lawson Health Research Institute at St. Joseph's Health Care London.

Research Interests / Specializations: Photoacoustic tomography, multispectral optical imaging, nanoscale optical devices, breast cancer detection

Matthew Cecchini, MD. PhD. FRCPC.

Associate Professor, Departments of Pathology and Laboratory Medicine, and Oncology. Schulich School of Medicine and Dentistry, Western University. Anatomical Pathologist, London Health Sciences Centre.

Research Interests / Specializations: Pulmonary pathology, head and neck pathology, molecular pathology and digital pathology, post-graduate medical education.

Lisa Cechetto, MBA, MSc.

Executive Director, Western Research, Western University. Former Director, WORLDiscoveries.

Joseph Chin, MD. FRCPC.

Professor Emeritus, Departments of Surgery, and Oncology, Schulich School of Medicine & Dentistry, Western University. Surgeon, Division of Urology, London Health Sciences Centre.

Research Interests / Specializations: Prostate Cancer Surgery, Minimally Invasive Surgery, Cryosurgery, High Intensity Focused Ultrasound (HIFU) Therapy

Seth Climans, MD. FRCPC.

Assistant Professor, Departments of Oncology, and Epidemiology & Biostatistics, Schulich School of Medicine & Dentistry. Neurologist and Neuro-Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Clinical Trials for Primary Brain Tumors. Targeted Therapies for Adolescent and Young Adult Glioma. Using Health Administrative Databases to answer Clinical neuro-oncology questions. Ethics and Palliative Care in Neuro-Oncology.

Derek W. Cool. MD. PhD. FRCPC.

Associate Professor, Department of Medical Imaging, and Oncology, Schulich School of Medicine & Dentistry, Western University. Vascular and Interventional Radiologist, London Health Sciences Centre. Associate Scientist, London Health Sciences Research Institute.

Research Interests / Specializations: Clinical Interests: Genitourinary and Oncology Interventions (prostate embolization for BPH, prostate cancer focal therapy, and renal cancer ablation). Research Interests: Medical Device Design, Image Fusion Technology to Map Pre-Operative to Intra-Operative Images to Enchance Minimally-Invasive Therapies.

Rohann Correa. MD. PhD. FRCPC.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Stereotactic Ablative Radiotherapy (SABR) for renal and prostate cancers, and obligometastatic disease. Metastastic directed therapies.

Gregory A. Dekaban, PhD.

Department Chair & Professor, Department of Microbiology & Immunology, Schulich School of Medicine & Dentistry, Western University. Director, Molecular Medicine, Robarts Research Institute. Scientist, Biotherapeutics Research Laboratory.

Research Interests / Specializations: Neurovirology, Neuroinflammation, Neurotrauma and therapeutics, Virology, HIV- AIDS disease pathogenesis and therapeutics, Dendritic cells and other antigen presenting cells as immunotherapeutics, In vivo cell tracking using bioluminescent and magnetic resonance imaging

Rodney DeKoter, PhD.

Professor, Department of Microbiology & Immunology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Scientist, Division of Genetics & Development, Children's Hospital Research Institute.

Research Interests / Specializations: Acute myeloid leukemia, childhood leukemia, transcriptional regulation

Fred Dick, PhD.

Professor, Departments of Pathology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Distinguished Scientist, Cancer Research Laboratory Program. Scientist, Children's Health Research Institute. Scientist, London Health Sciences Research Institute. Director, London Regional Transgenic and Gene Targeting Facility.

Research Interests / Specializations: Cancer genetics, genome instability, cancer dormancy, therapeutic resistance.

John Di Guglielmo, PhD.

Associate Professor, Departments of Physiology and Pharmacology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Acting Graduate Program Chair, Department of Physiology and Pharmacology.

Research Interests / Specializations: Regulation of subcellular trafficking and signaling of TGFβ receptors. Strategies to inhibit TGFβ signaling and epithelial to mesenchymal transition in tumor cells.

Gabriel DiMattia, PhD.

Associate Professor, Departments of Biochemistry, and Oncology, Schulich School of Medicine & Dentistry, Western University; Interim Director, Cancer Research Laboratory Program, London Health Sciences Research Institute.

Research Interests / Specializations: Ovarian Cancer: epigenetic control of cell viability; hypoxia effects on the epigenome; cancer initiating cells

Vanessa Dumeaux, PharmD, PhD.

Assistant Professor, Departments of Anatomy and Cell Biology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Principal Investigator.

Research Interests / Specializations: Systems biology of breast cancer, RNA-based biomarker signatures in blood.